Evidence map›Paper›PMID 41396402›Full record

ArticleClinical journal of gastroenterology2026

Cytomegalovirus-induced intrahepatic cholestasis complicated by hemophagocytic syndrome in an immunocompetent adult.

Naoya Omaru, Masahiro Takita, Ikue Sekai, Kosuke Minaga, Satoru Hagiwara, Misa Kojima, Osamu Maenishi, Yoshihide Ueda, Tomohiro Watanabe, Masatoshi Kudo

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Naoya OmaruDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.
Masahiro TakitaDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.
Ikue SekaiDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.
Kosuke MinagaDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.
Satoru HagiwaraDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.
Misa KojimaDepartment of Pathology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.
Osamu MaenishiDepartment of Pathology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.
Yoshihide UedaDepartment of Gastroenterology and Hepatology, Kakogawa Central City Hospital, 439 Honmachi, Kakogawa-Cho, Kakogawa, Hyogo, 675-8611, Japan.
Tomohiro WatanabeDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan. tomohiro@med.kindai.ac.jp.ORCID http://orcid.org/0000-0002-6175-8064
Masatoshi KudoDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Mihara-Dai 1-14-1, Minami-Ku, Sakai, Osaka, 590-0197, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactivation of cytomegalovirus (CMV) remains a significant concern in patients receiving immunosuppressive therapy. Although CMV infection and reactivation is associated with intrahepatic cholestasis in infants and immunosuppressive adults, intrahepatic cholestasis caused by CMV infection is rare in immunocompetent adults. Here, we report a case with CMV-induced intrahepatic cholestasis in an immunocompetent adult complicated by hemophagocytic syndrome (HPS). We excluded CMV infection from differential diagnosis of intrahepatic cholestasis based on serum CMV antibody profiles and immunocompetency at the initial assessment and then started oral administration of prednisolone (PSL). The development of CMV-induced lethal HPS after the treatment with PSL led us to reconsider the possibility of CMV infection as an etiology of cholestasis. Frozen serum before PSL administration exhibited a high copy number of CMV DNA and thus we reached the final diagnosis of CMV-induced intrahepatic cholestasis complicated by HPS. Resolution of cholestasis and HPS was achieved by ganciclovir. The patient exhibited elevated serum levels of IL-18, C-C motif chemokine ligand 2, and IL-13 with no alterations in serum levels of IFN-γ or TNF-α. This case underscores the importance of consideration of CMV reactivation as a differential diagnosis for intrahepatic cholestasis even in immunocompetent patients.

Indexed as

Cholestasis, IntrahepaticCytomegalovirus InfectionsLymphohistiocytosis, HemophagocyticAdultFemaleHumansImmunocompetenceMaleCytomegalovirusFerritinHemophagocytic syndromeIL-18Intrahepatic cholestasis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.